Page 7 - பிலிப்பைன் சமூகம் க்கு நுண்ணுயிரியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DOST eyes ivermectin trial in NCR quarantine facilities by May enablePagination: false endIndex: Metro Manila (CNN Philippines, April 29) The national government is finalizing details of the clinical trial on the antiparasitic drug ivermectin since there is still no evidence it is effective against COVID-19. Dr. Jaime Montoya, chief of the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD), said they are targeting to start the trial by end of May or first week of June. Over 1,200 mild to moderate COVID-19 patients undergoing isolation in quarantine facilities could participate in the trial, but the number could eventually go up. The clinical trial - personally ordered by President Rodrigo Duterte - could run for six months or less, but it should be completed before yearend.

Metro manilaPhilippines generalEric domingoRodrigo duterteMarissa alejandriaJaime montoyaPhilippine council for health researchDepartment of scienceDepartment of healthWorld health organizationDrug administrationPhilippine society for microbiologyTechnology philippine councilHealth researchPresident rodrigo dutertePhilippine society